In spite of the very low or absent expression of ICP on NKT-like cells, we observed an increased fraction of NKT-like cells expressing TIM-3 and/or LAG-3 in treated CML patients and decreased expression of LAG-3 associated to deep molecular response. This evidence concerns the gene LAG3 and chronic myelogenous leukemia, BCR-ABL1 positive.